 |
bortezomib |
|---|---|
| Trade Name | Velcade |
| Orphan Indication | Mantle cell lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2012-05-30 00:00:00 |
| Sponsor | Millennium Pharmaceuticals, Inc.;40 Landsdowne Street;Cambridge, Massachusetts, 02139 |
| |
bortezomib |
|---|---|
| Trade Name | Velcade |
| Orphan Indication | Mantle cell lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2012-05-30 00:00:00 |
| Sponsor | Millennium Pharmaceuticals, Inc.;40 Landsdowne Street;Cambridge, Massachusetts, 02139 |